Alzheimer's Disease Clinical Trials

46 trials recruiting in Canada.

Brain & Nervous System

Recruiting Drug Device Behavioral Older adults Healthy volunteers

7 trials

Testing ARO-MAPT-SC against a placebo for alzheimer disease

Explore this study →

There are 2 groups in this study. Group A receives ARO-MAPT-SC. Group B, the placebo group, receives Placebo.

Sites in East York, Montreal and 1 more city

Phase 1
2 groups
Sites in East York, Toronto and 1 more city
Recruiting

Official title: Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease

Alzheimer Disease · Arrowhead Pharmaceuticals

Testing Remternetug (SC) against a placebo for alzheimers disease

Explore this study →

There are 3 groups in this study. Group A receives Remternetug (SC). Group B, the placebo group, receives Matching Placebo (Remternetug). Group C, the comparison group, receives Remternetug (SC).

Sites in Québec, Toronto and 2 more cities

Phase 2
3 groups
Sites in Vancouver, Toronto and 2 more cities
Recruiting

Official title: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Alzheimers Disease · Washington University School of Medicine

Testing Remternetug against a placebo for alzheimers disease

Explore this study →

There are 3 groups in this study. Group A receives Remternetug. Group B, the placebo group, receives Matching Placebo (Remternetug). Group C, the comparison group, receives Remternetug.

Sites in Québec, Toronto and 2 more cities

Phase 2
3 groups
Sites in Vancouver, Toronto and 2 more cities
Recruiting

Official title: A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Alzheimers Disease · Washington University School of Medicine

Get matched to the best-fit trials

Answer a few questions and we'll find the closest matches for alzheimer's disease.

Testing Daridorexant against a placebo for alzheimer disease (AD)

Explore this study →

There are 2 groups in this study. Group A receives Daridorexant 50 mg. Group B, the placebo group, receives Placebo.

One site, in Montreal

Phase 2
2 groups
One site, in Montreal
Recruiting

Official title: Daridorexant for Alzheimer Disease Prevention

Alzheimer Disease (AD) · Douglas Mental Health University Institute

Testing Deep Brain Stimulation of the for alzheimer disease

Explore this study →

Everyone in this study is in one group and receives Deep Brain Stimulation of the Pedunculopontine Nucleus.

One site, in Toronto

1 group
One site, in Toronto
Recruiting

Official title: Deep Brain Stimulation of the Pedunculopontine Nucleus for Alzheimer's Disease

Alzheimer Disease · University Health Network, Toronto

Testing Brain Health PRO for dementia prevention

Explore this study →

There are 2 groups in this study. Groups A and B receive Brain Health PRO.

One site, in Vancouver

2 groups
One site, in Vancouver
Recruiting

Official title: The Brain Health PRO Online Risk Factor Reduction Study to Prevent Dementia

Dementia Prevention · University of British Columbia

Testing (18F)-FEPPA for frontotemporal dementia

Explore this study →

Everyone in this study is in one group and receives (18F)-FEPPA.

One site, in London

1 group
One site, in London
Recruiting

Official title: Molecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias

Frontotemporal Dementia · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Looking for the closest fit?

Get matched →

Ask someone to look with you

Whether or not the results above are what you were looking for, someone at Concord can search with you.

Get notified when a matching trial opens

We'll watch for Alzheimer's Disease trials near you.

← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.